Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

In vitro, in vivo and ex vivo demonstration of the antitumoral role of hypocretin-1/orexin-A and almorexant in pancreatic ductal adenocarcinoma
Stéphanie Dayot, Daniela Speisky, Anne Couvelard, et al.
Oncotarget (2018) Vol. 9, Iss. 6, pp. 6952-6967
Open Access | Times Cited: 25

Showing 25 citing articles:

The neural addiction of cancer
Claire Magnon, Hubert Hondermarck
Nature reviews. Cancer (2023) Vol. 23, Iss. 5, pp. 317-334
Closed Access | Times Cited: 51
Orexins as Novel Therapeutic Targets in Inflammatory and Neurodegenerative Diseases
Alain Couvineau, Thierry Voisin, Pascal Nicole, et al.
Frontiers in Endocrinology (2019) Vol. 10
Open Access | Times Cited: 66
Orexin‐A mediates glioblastoma proliferation inhibition by increasing ferroptosis triggered by unstable iron pools and GPX4 depletion
Rengzheng Huan, Jiqin Zhang, Jianhe Yue, et al.
Journal of Cellular and Molecular Medicine (2024) Vol. 28, Iss. 9
Open Access | Times Cited: 6
Focus on the Complex Interconnection between Cancer, Narcolepsy and Other Neurodegenerative Diseases: A Possible Case of Orexin-Dependent Inverse Comorbidity
Maria P. Mogavero, Alessandro Silvani, Lourdes M. DelRosso, et al.
Cancers (2021) Vol. 13, Iss. 11, pp. 2612-2612
Open Access | Times Cited: 28
The Orexin receptors: Structural and anti-tumoral properties
Alain Couvineau, Pascal Nicole, Valérie Gratio, et al.
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 20
Sleep and Cancer
Courtney M. Vaughn, Bradley V. Vaughn
Cancers (2025) Vol. 17, Iss. 6, pp. 911-911
Open Access
The Anti-tumoral Properties of Orexin/Hypocretin Hypothalamic Neuropeptides: An Unexpected Therapeutic Role
Alain Couvineau, Stéphanie Dayot, Pascal Nicole, et al.
Frontiers in Endocrinology (2018) Vol. 9
Open Access | Times Cited: 32
Ectopic expression of OX1R in ulcerative colitis mediates anti-inflammatory effect of orexin-A
Nassima Messal, Neïké Fernandez, Stéphanie Dayot, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2018) Vol. 1864, Iss. 11, pp. 3618-3628
Closed Access | Times Cited: 27
Orexins: A promising target to digestive cancers, inflammation, obesity and metabolism dysfunctions
Alain Couvineau, Thierry Voisin, Pascal Nicole, et al.
World Journal of Gastroenterology (2021) Vol. 27, Iss. 44, pp. 7582-7596
Open Access | Times Cited: 16
The Orexin-A/OX1R System Induces Cell Death in Pancreatic Cancer Cells Resistant to Gemcitabine and Nab-Paclitaxel Treatment
Thierry Voisin, Pascal Nicole, Valérie Gratio, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 11
Orexins in apoptosis: a dual regulatory role
Simona Cavalu, Sameh Saber, Rabab S. Hamad, et al.
Frontiers in Cellular Neuroscience (2024) Vol. 18
Open Access | Times Cited: 2
Orexins/Hypocretins and Cancer: A Neuropeptide as Emerging Target
Alain Couvineau, Nicole Pascal, Gratio Valérie, et al.
Molecules (2021) Vol. 26, Iss. 16, pp. 4849-4849
Open Access | Times Cited: 15
Antitumoral Effect of Laurinterol on 3D Culture of Breast Cancer Explants
Sara García-Davis, Ezequiel Viveros‐Valdez, Ana R. Díaz‐Marrero, et al.
Marine Drugs (2019) Vol. 17, Iss. 4, pp. 201-201
Open Access | Times Cited: 16
Protective Effects of Orexin A in a Murine Model of Cisplatin-Induced Acute Kidney Injury
Jungmin Jo, Jung‐Yeon Kim, Jaechan Leem
Journal of Clinical Medicine (2022) Vol. 11, Iss. 23, pp. 7196-7196
Open Access | Times Cited: 9
Involvement of the Orexinergic System in Cancer: Antitumor Strategies and Future Perspectives
Pilar Marcos, Rafael Coveñas
Applied Sciences (2023) Vol. 13, Iss. 13, pp. 7596-7596
Open Access | Times Cited: 5
Machine Learning Models to Predict Ligand Binding Affinity for the Orexin 1 Receptor
Vanessa Zhang, Shayna L. O’Connor, William J. Welsh, et al.
Artificial Intelligence Chemistry (2023) Vol. 2, Iss. 1, pp. 100040-100040
Open Access | Times Cited: 4
Knockdown of type 2 orexin receptor in adult mouse testis potentiates testosterone production and germ cell proliferation
Pratikshya Sahoo, Debarshi Sarkar, Shubhangi Sharma, et al.
Molecular and Cellular Endocrinology (2024) Vol. 592, pp. 112312-112312
Closed Access | Times Cited: 1
Examining the Role of Histaminergic, Orexinergic, and Cannabinergic Systems in Redox Regulation in Gastric Adenocarcinoma
Ana Laura Torres-Román, Karla Lucero Rodríguez-Flores, Víctor Manuel Hernández-Mora, et al.
Mini-Reviews in Medicinal Chemistry (2023) Vol. 23, Iss. 18, pp. 1806-1817
Closed Access | Times Cited: 2
Imaging flow cytometry of tumoroids: A new method for studying GPCR expression
Valérie Gratio, Stéphanie Dayot, Samira Benadda, et al.
Cytometry Part A (2023) Vol. 105, Iss. 4, pp. 276-287
Open Access | Times Cited: 2
Heteroaryl derivatives of suvorexant as OX1R selective PET ligand candidates: Cu-mediated 18F-fluorination of boroxines, in vitro and initial in vivo evaluation
Kim-Viktoria Bolik, Jan Hellmann, Simone Maschauer, et al.
EJNMMI Research (2024) Vol. 14, Iss. 1
Open Access
Bioinformatic analysis of neuropeptide related genes in patients diagnosed with invasive breast carcinoma
Fatih Yay, Durmuş Ayan
Computers in Biology and Medicine (2024) Vol. 183, pp. 109304-109304
Closed Access
Pharmacodynamics of the orexin type 1 (OX1) receptor in colon cancer cell models: A two‐sided nature of antagonistic ligands resulting from partial dissociation of Gq
Valérie Gratio, Paulina Dragan, Luis Garcı́a, et al.
British Journal of Pharmacology (2024)
Open Access
C-terminal peptide of preproorexin enhances brain-derived neurotrophic factor expression in rat cerebrocortical cells and recognition memory in mice
Hiroshi Tsuneki, Kosuke Honda, Y. Sekine, et al.
European Journal of Pharmacology (2023) Vol. 964, pp. 176306-176306
Open Access | Times Cited: 1
Tumor cell apoptosis mediated by the orexins
Anastasiia Diatlova, Н. С. Новикова, К. З. Деревцова, et al.
Medical Immunology (Russia) (2021) Vol. 23, Iss. 3, pp. 421-438
Open Access | Times Cited: 1
Cancer and sleep: is cancer a circadian rhythm disorder?
Courtney M. Vaughn, Bradley V. Vaughn
Elsevier eBooks (2021), pp. 460-481
Closed Access
Page 1

Scroll to top